ASHPOfficial

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Allison Given, PharmD candidate at the University of Charleston, College of Pharmacy as she shares what drew her to a career in pharmacy, her experiences with clinical pharmacists as a cystic fibrosis patient, and the patient interactions she’s already had as a pharmacy student. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join Sandra Kane-Gill and Katie Suda to discuss changes in research including open access requirements, getting funding, and artificial intelligence and implications for pharmacist researchers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Cher Enderby sits down with the Section of Pharmacy Educators Awardee Lea Eiland to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on the pharmacists role in Myasthenia Gravis. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Patricia Kienle, Cardinal Health, and Mike Ganio , ASHP , join us to discuss the compounding educational line up at the ASHP Pharmacy Futures meeting in June and explain the unique opportunity to participate in the Designated Person Program that offers a live skills workshop on Wednesday June 11th. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Nancy MacDonald, Immediate Past Chair of the Section of Clinical Specialists and Scientists sits down with Distinguished Service Awardee Bhavik Shah to discuss his service and leadership within ASHP. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores the intersection of pharmacy and technology, focusing on how machine learning (ML) models are being used to predict medication non-adherence in patients with inflammatory bowel disease (IBD). Dr. Gina Luchen, Director of Digital Health and Data at ASHP and Dr. Christian Rhudy, Associate Director of Quality and Outcomes Research at the University of Kentucky HealthCare discuss Dr. Rhudy’s recent ML model research, key findings, and the potential applications of these models across different patient populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Chelsea Renfro and Dr. Autumn Zuckerman discuss the AJHP Special Feature, “Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Emily Bryant, Clinical Pharmacist and Residency Program Coordinator at Aurora Health Care, as she shares insights on her pharmacy career journey, her experiences working with pharmacy students and residents, and the various roles of pharmacists as medication experts in a hospital setting. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast dives into the innovative PGY2 Medication-Use Safety and Policy (MUSP) residency programs at City of Hope. These groundbreaking programs, developed in collaboration with Chapman University and Becton Dickinson, offer residents unique opportunities in academia and medical technology, providing comprehensive training that redefines advanced pharmacy education. Join us as we explore how these residencies are shaping the future of medication safety, hear firsthand experiences from current residents, and discuss the impact of blending academic and industry expertise. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Kelli Johnson sits down with the Pharmacy Technician Forum (now The Pharmacy Technician Society) Awardee Charlotte Hook to discuss what forum membership, TPTS, and ASHP means to her and how it has helped her develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on opioid REMS. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Drs. Rena Gosser, Christopher Scott, and Johnathan Watanabe discuss the ASHP/ASHP Foundation 2025 Pharmacy Forecast Report with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Creating interprofessional experiences between didactic pharmacy students and perscribers can be challenging for all schools/colleges of pharmacy, yet these experiences remain an important part of the student experience and accreditation standards. Some schools face additional geographic and institutional barriers based on their physical location and the programs offered by their colleges/universities. Join us as we hear from a panel of faculty and administrators who have implemented creative solutions to successfully deliver exceptional interprofessional experiences. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for this podcast episode where four 2024 ASHP Fellows discuss their journeys in pharmacy leadership. They’ll share valuable insights and advice for pharmacists, especially for new practitioners, who aspire to become leaders in the profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

How rare are rare diseases, really? Discover the critical role pharmacists play in enhancing care, advancing practice, and fostering inclusion for individuals living with rare diseases. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. Hosted by Rachel Hawley, this month's episode features Linda Gordon, System Director of Diversion Prevention at UC Health, as she shares insights on her pharmacy career journey, the collaborative nature of interprofessional care teams, and the growing impact of AI in pharmacy practice. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

NIOSH published an updated list of hazardous drugs in healthcare settings in December, 2024 – its first update in nearly 8 years. The new list includes significant changes that affect how USP Chapter <800> can be applied to some hazardous drugs. Experts discuss the updated list and its implications for pharmacy practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we explore the evolving role of pharmacy technicians and how PAI 2030 is shaping the future of pharmacy practice. Our guests discuss advanced technician responsibilities like technician product verification, regulatory compliance, and the importance of formal career paths and certifications. Tune in to hear insights on how these changes are positively impacting patient care and the dynamics of pharmacy teams. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Tracy Anderson-Haag, Dr. Sandra Kane-Gill, and Dr. Andrew Webb discuss the AJHP Descriptive Report, “Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Solid organ transplant pharmacy is a multi-faceted field that offers opportunities to practice in either the inpatient or outpatient setting. This discussion focuses on what the role of a transplant pharmacist may look like in an ambulatory care setting, considerations when initiating or expanding outpatient pharmacy services, as well as the potential obstacles faced by solid organ transplant pharmacists. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform pharmacy practice. This podcast will outline and discuss how artificial intelligence is and how can it be utilized within the profession of pharmacy and pharmacy education The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode of We’re Your Pharmacist podcast series, ASHP sits down with Ashley Ramp, Multi-Site Director of Pharmacy at Children's Hospital Colorado. Ashley shares her journey of becoming a pharmacist, where she draws inspiration, and her experience transitioning careers from being a high school teacher to health-system pharmacist. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2024 Midyear Clinical Meeting & Exhibition in New Orleans, LA. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be - there is nothing like it! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

There’s Nothing Like It is the theme for the ASHP Midyear Clinical Meeting 2024 and there’s nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Antifungal therapeutic drug monitoring is a critical component of individualized, precision treatment for fungal infections and for antifungal stewardship. Antifungal therapeutic drug monitoring can help improve outcomes through minimizing toxicity associated with supratherapeutic drug levels and prevent treatment failure from subtherapeutic levels. Also, in vitro studies have shown that suboptimal drug levels can lead to antifungal resistance, supporting therapeutic drug monitoring's potential role in preventing the emergence of antifungal-resistant organisms. This episode podcast, we discuss outcome data when antifungal TDM is used, role of antifungal TDM with isavuconazole and echinocandins, TDM in outpatient settings, and other controversies. We will also highlight the recent antifungal TDM insights published by SIDP. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Besides remembering the counseling advice of not placing ear drops into eyes, there aren’t many ophthalmologic key points that pop into your mind. This podcast session will help open your eyes (pun intended) to commonly used eye therapies within the emergency department. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

According to the CDC, nearly 42% of Americans have obesity, with estimated medical costs of $173+ billion dollars annually. While medications to promote weight loss have become popular, it is equally important to also review current medications for those that may lend to weight gain. Optimizing these medications with weight neutral or weight negative alternatives can help patients achieve greater success in their weight loss efforts. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Emily Doycich sits down with VA pharmacists Susan Duquaine and Abbey Loy to discuss best practices for implementing a pharmacogenomics program withing a health system including clinical and operational considerations along with how they addressed barriers and keep up with this ever-evolving area of pharmacy practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we dive into 'Race-Based Clinical Calculations Causing Healthcare Disparities,' an essential session from the Midyear Clinical Meeting and Exhibition. We'll explore the reasons this topic matters, actionable steps listeners can take to address these disparities, and the unique benefits of attending Midyear for professional growth. Don't miss out on this critical discussion shaping the future of equitable healthcare! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The podcast will discuss optimizing the diagnosis, antimicrobial selection, and duration of therapy for adult patients with community-acquired pneumonia admitted to the hospital. This engaging conversation will bring the guidelines to life as an emergency medicine antimicrobial stewardship physician and an infectious diseases clinical pharmacist discuss navigating patients from hospital arrival through admission and how stewardship plays an immediate role in the patient care plan. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this first in a series, Christi Jen and Holly Geyer sit down with Libby Johnson to discuss the creation of an opioid stewardship program, including the identification of key stakeholders, guidelines to follow as well as initial goals for a newly founded opioid stewardship program. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join ASHP host Cindy Von Heeringen as she discusses the 2025 ASHP Pharmacy Forecast and associated Midyear session with Joe DiPiro (Forecast Editor), Rena Gosser (Advisory Committee member), and James Hoffman (Forecast Deputy Editor). The 2025 ASHP Pharmacy Forecast will be published in AJHP in December in conjunction with the Midyear session. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we look at the rise of so-called “PBM Group Purchasing Organizations” – affiliated entities recently established by each of the major PBMs. Critics allege that PBM GPOs do not add value to the healthcare system and function solely to enable PBMs to collect excessive profits. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In celebration of Veterans Day 2024, @ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with Peter Bulatao, Aaron Middlekauff, and Ryan Lampien about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we discuss the safety and efficacy of administering undiluted levetiracetam via IV push as well as the considerations for incorporating this practice into pharmacy and nursing workflows. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s Senior education director, Cindy von Heeringen is joined by Dr. Alex Infante, Clinical Assistant Professor at Texas A&M University and Dr. Jennie Jarrett, Director of Science and Drug Policy at the American Medical Association as they discuss their upcoming Midyear session that focuses on the ability of pharmacists to use available resources and strategies to positively impact patient care by overcoming barriers in the implementation and utilization of harm reduction services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Emergency medicine organizations have declared that racism is a public health crisis. Our panelists will discuss treatment inequities identified within emergency and prehospital medicine, populations at risk of discrimination, and research opportunities to further describe our current state and future opportunities. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP welcomes Dr. Kate Cozart, Clinical Pharmacist Practitioner, Primary Care, PGY1 Residency Program Coordinator, U.S. Department of Veterans Affairs and Dr. Amy Henneman, Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy and Health Sciences as they join Senior Education Director Cindy von Heeringen for a chat about their upcoming midyear session focused on professional identity formation as a strategy to prevent burnout for both pharmacists and technicians. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on how generative artificial intelligence (AI) impacts inpatient pharmacy practice. We will focus on current technologies and future applications of generative AI in this space. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast discusses the two models of infusion services to facilitate outpatient and home health care, and the care benefits and challenges associated with therapy. A patient care goal is to enhance the care experience and best streamline infusion therapy through a modality that is most efficient, while equally safe, and less disruptive to day-to-day activities. Health-systems have developed strategies for optimizing a balance between the use of home infusion and hospital outpatient infusion services to ensure optimal patient care and financial performance. Payers implement a variety of tools that enhance care affordability based on formulary status, site of care restrictions, and medication dispensing model (i.e. brown bagging, white bagging, etc.). Proposed legislative policies and regulatory reforms that impact Medicare payments may have a key role towards infusion services through changes in the payment structure. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Community health Workers play a role in improving health outcomes and public health by connecting patients with community resources. In this podcast episode, we discuss key takeaways from a research project evaluating the impact of interprofessional collaboration with community health workers on pharmacy students’ knowledge of social determinants of health. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

John Arnold, PhD, RPh , Director of Non-Degree Programs at Samford University and Matt Rewald, BS, CPhT, DPLA Assistant Professor of Pharmacy at the Mayo Clinic, join ASHP host Cindy von Heeringen, Senior Education Director on the National Meetings team to discuss their upcoming Midyear session, Empowering Tomorrow's Pharmacy Technicians: Fostering Partnerships with Academia to Develop Cutting-Edge Technician Training Programs. The speakers highlight a unique opportunity to augment technician training by partnering with schools of pharmacy and using the infrastructure and resources to potentially mitigate the technician shortage with another pathway for developing the profession. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. In this episode, we look at how insurers leverage practices restricting acquisition and administration of infused medications to steer patients towards insurer-owned providers and explore how these policies impact pharmacists, patients, and overall quality of care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.